There were 642 press releases posted in the last 24 hours and 169,915 in the last 365 days.

Kathy Bates to lead LE&RN charge on Capitol Hill in fight against LE & LD

Kathy Bates, 2018 #DCLymphWalk Lincoln Memorial

Kathy Bates, 2018 #DCLymphWalk Lincoln Memorial

LE&RN Activists at 2018 #DCLymphLobby, Capitol Hill

LE&RN Activists at 2018 #DCLymphLobby, Capitol Hill

Kathy Bates with Representative Ted Lieu (D-CA)

Kathy Bates meets with Representative Ted Lieu (D-CA) to discuss LE and LD

LE&RN activists will meet lawmakers on 3/29/19; followed by 3/30/19 Lincoln Memorial Walk & Rally

I will continue this fight until our lawmakers recognize how crucial this is to millions of Americans and hundreds of millions around the world.”
— Kathy Bates
NEW YORK, NY, USA, January 3, 2019 / -- Kathy Bates, Academy Award-winning Actress, is a longtime and outspoken advocate for the lymphedema (LE) and lymphatic disease (LD) communities, primarily through her role as Spokesperson for the Lymphatic Education & Research Network (LE&RN). For the second year, Ms. Bates will bring the power of her celebrity and her passion for the cause to Capitol Hill, leading like-minded activists in a day filled with Congressional office meetings in the fight against LE and LD. The next day, activists will meet on the steps of the Lincoln Memorial for the second annual DC Walk & Rally to Fight Lymphedema & Lymphatic Diseases.

“Only those who struggle with LE and LD know what it’s like to battle these diseases every day,” said Kathy Bates. “So, I’ll be making my way, alongside an army of activists, to tell our lawmakers that we are here, and we have demands. We want a cure – and a cure that not only prevents progression, but that reverses LE and LD. Until then, we need greater awareness in the medical community and more money for research. I will continue this fight until our lawmakers recognize how crucial this is to millions of Americans and hundreds of millions around the world.”

“LE&RN Spokesperson Kathy Bates has proven to be a force to be reckoned with on Capitol Hill, and she never gives up,” said William Repicci, LE&RN President & CEO. “On March 29, we will once again gather in Washington, D.C. to ask Congress to ensure that $70 million of the National Institutes of Health’s increased budget will be allocated to lymphatic research. We will also advocate for the Department of Defense to include “lymphatic diseases” as a medical research area and will urge the passage of the Lymphedema Treatment Act (LTA), which would ensure Medicare coverage for medically necessary compression garments. We won’t stop until Congress responds to the needs of our too-often-ignored communities.”

Sign up to join other activists from around the world for LE&RN’s DC Lobby Day (March 29) at Registration is free, and no experience is needed, just a desire to raise awareness and to make change happen. Registration must be completed by Monday, March 11. All Lobby Day registrants will receive an email with further details, including a discount code for the March 30 Walk & Rally to Fight Lymphedema & Lymphatic Diseases at the Lincoln Memorial. Social media activists: use hashtags #DCLymphWalk and #DCLymphLobby.

About LE&RN
Founded in 1998, the Lymphatic Education & Research Network (formerly LRF) is a 501(c)(3) not-for-profit organization whose mission is to fight lymphatic disease and lymphedema through education, research and advocacy. LE&RN provides valuable educational resources for the millions of people who suffer from lymphedema and lymphatic disease. LE&RN fosters and supports research that can deepen the medical community's understanding of the lymphatic system. For more information about lymphatic diseases or the Lymphatic Education & Research Network, please visit or call (516) 625-9675.

Laura Farrell
Lymphatic Education & Research Network
(516) 625-9675
email us here
Visit us on social media:

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.